Glioblastoma (GBM) is the most prevalent primary malignancy of the central nervous system with obvious aggressiveness, and is associated with poor clinical outcome. 
36.5%. 3 Even with numerous clinical trials conducted with different agents, there has been no proven success in terms of efficacy. 4 Furthermore, the understanding of the biology of glioma is limited. Calcium ion (Ca 2+ ) has been regarded as a dominant secondary messenger in eukaryotic cells. Emerging reports indicate that Ca 2+ could serve as an essential positive modulator, as it influences the progression of GBM via enhanced quiescence, proliferation, migration and maintenance of malignant cells. 5 Considering treatment approaches that block structures relying on Ca
2+
, such as channels and pumps, can never cure GBM. 5 However, various approaches relying on Ca 2+ utilization by cells in order to conquer checkpoints can be exploited to reprogram malignant stem cells to a different destiny.
The visinin-like protein (VILIP) superfamily, includes VILIP1, VILIP2, VILIP3 (also called HPCAL1), neurocalcin-δ and hippocalcin. [6] [7] [8] Biological activities of the proteins belonging to this family are atypical. It has been reported that VILIP1 suppresses the invasiveness and proliferation of squamous cell carcinoma cells via inhibiting the function of matrix metalloproteinase-9 and RhoA. Furthermore, VILIP1 also inhibits cancer progression via down-regulation of α5
and αV integrins. 9 Some studies have proved that the expression of HPCAL1 mainly occurred in the Purkinje cells of brain, and the protein HPCAL1 might participate in the regulation of neuron types. 6 Studies have also indicated that reinforced expression of HPCAL1 stimulated ERK2 and its expression. 10 It has been recognized that HPCAL1 is an innovative inhibitor of liver cancer, which was downregulated in the hepatocellular carcinoma (HCC) tissues and cells.
Suppressed HPCAL1 expression worsened clinical outcome in patients with HCC. 11 On the contrary, interaction between HPCAL1
and wild-type paired-like homeobox 2b (WT PHOX2B) influenced the outgrowth of neurites in human neuroblastoma cells with
PHOX2B expression. Elimination of the interaction by HPCAL1
knockdown with small hairpin RNA (shRNA) in the neuroblastoma cells with PHOX2B expression reduced the outgrowth of neurites.
Furthermore, the transcriptional profile predicted suppressed differentiation of sympathetic neurons. 12 The understanding of the influence of HPCAL1 on the development of GBM cells is limited.
The present study evaluated the effect of: (a) overexpression of HPCAL1 in the tissues and cells obtained from patients with GBM, and (b) abnormally stimulated Wnt/β-catenin axis in order to enhance cell growth. Stimulation of HPCAL1 was regulated via Ca 2+ concentration within the cells, which enhances ERK stimulation and inhibits the enzyme glycogen synthase kinase 3 beta (GSK3β). The findings of the present study will elucidate the innovative effects of HPCAL1 on progression of GBM, and also offer a promising strategy to treat GBM. Puromycin was used for the selection of transfected cells.
| MATERIALS AND METHODS

| Clinical specimens
| Analysis of β-catenin nuclear localization
Immunofluorescence was used to evaluate nuclear β-catenin in the cells LN-18 and A172. 14 Nikon fluorescence microscope (type TS800) supplemented with a SPOT camera and imaging software was used for observation.
| TOPflash reporter assay
Transfection assay was conducted with β-catenin/T cell factor (TCF)
reporter plasmid (TOPflash). 
| MTT assay
MTT assay (Promega) was used to evaluate the proliferation capabil- 
| In vivo tumour assay
| Statistical analysis
GraphPad Prism V software was used for statistical analysis. The data were regarded as significant at P < 0.05. The results are presented as means ± SD.
| RESULTS
| HPCAL1 was up-regulated via Ca
2+ in GBM in vivo and in vitro
To investigate the influence of HPCAL1 on GBM, we firstly detected (BAPTA-AM) exhibited opposite effects ( Figure 1F ). These findings suggest that HPCAL1 expression was enhanced in GBM specimens, and it relied on Ca 2+ concentration.
| HPCAL1 enhanced GBM proliferation
To investigate the influence of HPCAL1 on biological activities of 
| HPCAL1 stimulated β-catenin expression via
GSK3β phosphorylation
The present study also investigated the mechanisms of regulation of Wnt/β-catenin axis via HPCAL1 to enhance the progression of GBM.
The concentration of β-catenin was modulated via protein degeneration mediated by ubiquitin/proteasome after its phosphorylation via GSK3β, 16 and its kinase function was determined via suppressed Ser9 phosphorylation. 17 It was found that Ser9 phosphorylation of GSK3β was significantly decreased after HPCAL1 knockdown in the cells A172, U-118MG and U-87MG ( Figure 5A ; Figure S1A 
| DISCUSSION
Glioblastoma is the most prevalent cancer with noticeable aggressiveness in brain. Relationship between cancer growth and proliferation indicates that various cancer stages preserve molecular features for a specific period of the development of autonomic system. 18 Studies on regulation of proliferation and differentiation of malignant cells throw light on GBM and also an innovative therapeutic strategy. Emerging reports indicate that Ca 2+ could play a crucial part in positive regulation of initiation of GBM by affecting the maintenance, migration, quiescence and proliferation of malignant cells. 5 As calcium pathway has been recognized to regulate diverse cellular reactions, it can be presumed that the pathway influences the progression of malignancy. 19 Up-regulation of HPCAL1 has been demonstrated in patients with GBM. 12 In the present study, there with regard to generation and progression of malignancies is limited.
In our study, we found that HPCAL1 expression was positively asso- lead to enhanced oxidative stress, and increased the apoptosis in neuron, which will result in Alzheimer's disease. 22 Thus, increased expression of HPCAL1 may be protective for neuron against oxidative stress, and promotes neuron cell growth. Consistently, we also found that the increased Ca 2+ level in GBM promote the expression of HPCAL1, and enhanced the GBM cell proliferation. Silence of HPCAL1 abolished the proliferation effect of Ca 2+ in GBM cells (Figure 2E ), but enhanced expression of HPCAL1 reversed the suppression effect of Ca 2+ scavenger on GBM proliferation ( Figure 2F ).
These results suggested that HPCAL1 should be the Ca 2+ sensor in the GBM cell proliferation. However, the detail mechanism for HPCAL1 induction by Ca 2+ level still remain unclear, and worth more efforts to be further investigated.
The up-regulation of HPCAL1 stimulated the Erk-Wnt/β-catenin axis, which led to the proliferation of GBM cells. Further, the present study highlighted the influence of HPCAL1 on enhancing the progression of GBM. Extracellular signal-regulated protein kinases 1 and 2 are a part of mitogen-stimulated protein kinase family, which regulates proliferation of cells. Several studies have suggested that stimulation of Ras-Raf-MEK-ERK axis [23] [24] [25] and Raf-MEK-ERK axis can result in glioma. 26 In the present study, our results showed that the increased intracellular Ca 2+ enhanced the expression of HPCAL1 followed by enhanced ERK activity. Consequently, the wnt/β-catenin pathway was activated and promotes the proliferation ability of glioma cells. Furthermore, ERK and MEK were abnormally stimulated in gliomas and other malignancies, 27 and could serve as an upstream event, and is necessary to deactivate GSK3β. 17 Previous studies have demonstrated the interaction between ERK2 and HPCAL1.
11 Accordingly, our results provided also suggested that the expression of HPCAL1 lead to the activation of ERK, which would deactivate GSK3β, and therefore constrain the activity of β-catenin. However, the precise mechanism of interaction between ERK and HPCAL1 in GBM requires further exploration.
It has been demonstrated that the Wnt/β-catenin axis participates in GBM 28 The expression of β-catenin was enhanced in several GBM cells, thus triggering Wnt target genes and promoting proliferation, 29 invasion and migration. 30 Findings of the present study suggest that HPCAL1 is an upstream effector of the Wnt/β-catenin axis of GBM. This is implied by a close relationship between the promoted expression of HPCAL1, aggregation of c-Myc, β-catenin and CCND1 in GBM, and inhibition of Wnt via exhaustion of HPCAL1 in GBM cells. HPCAL1 can assist in preserving cytosolic β-catenin, which binds to some proteins and enhances their turnover rate.
Besides HPCAL1, other abnormalities of GBM can also stimulate Wnt, including overexpression of Wnt ligand 31 and down-regulation of antagonists of Wnt. 29 The function of Wnt and malignant stemness was modulated via the micro-environment, where agents, such as growth factor of liver cells generated via myofibroblasts, stimulated transcription relying on β-catenin and promoted cancer stem cell clonogenicity. 32 No mutation specific to β-catenin in GBM has been reported. Promoter hypermethylation of Wnt pathway suppressors, such as NKD2 and sFRP2, has been frequently reported in numerous GBMs. 33 Findings of the present study indicate that HPCAL1 stimulates the Wnt pathway by enhancing ERK and indirectly inactivating GSK3β, thus enhancing β-catenin nuclear translocation. As β-catenin is also involved in GBM metastasis, 30 we believed that HPCAL1 might also have function to promote GBM cell invasion and migration. Therefore, further studies focusing on the expression of HPCAL1 that propels proliferation and migration of GBM are necessary.
The results of the present study proved the influence of HPCAL1 on the stimulation of Wnt/β-catenin axis and proliferation of GBM.
Future research on the functional effect of HPCAL1 can offer innovative strategies to identify pharmacological or biological targets of GBM.
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